UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Normalization of HE-stained histological images using cycle consistent generative adversarial networks

Diagnostic pathology, 2021-08, Vol.16 (1), p.71-71, Article 71

2021

Volltextzugriff (PDF)

Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma

European journal of haematology, 2016-10, Vol.97 (4), p.379-386

2016

Volltextzugriff (PDF)

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease : Potential for a prognostic factor

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5516-5519

2005

Volltextzugriff (PDF)

In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration

PloS one, 2012, Vol.7 (1), p.e30422-e30422

2012

Volltextzugriff (PDF)

Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer

Clinical cancer research, 2005-08, Vol.11 (16), p.5993-6001

2005

Volltextzugriff (PDF)

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours

European journal of cancer (1990), 2015-01, Vol.51 (2), p.146-156

2015

Volltextzugriff (PDF)

Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy

Clinical cancer research, 2008-10, Vol.14 (20), p.6574-6579

2008

Volltextzugriff (PDF)

T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals

World journal of gastroenterology : WJG, 2008-04, Vol.14 (16), p.2529-2533

2008

Volltextzugriff (PDF)

Toll-like receptor 9 agonists as cancer therapeutics

Expert opinion on investigational drugs, 2011-03, Vol.20 (3), p.361-372

2011

Volltextzugriff (PDF)

Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters

Journal of clinical oncology, 2002-11, Vol.20 (21), p.4338-4343

2002

Volltextzugriff (PDF)

In vivo Expansion of Naïve CD4+CD25high FOXP3+ Regulatory T Cells in Patients with Colorectal Carcinoma after IL-2 Administration

PloS one, 2012-01, Vol.7 (1), p.e30422

2012

Volltextzugriff (PDF)

Analysis of Tie2-Expressing Monocytes (TEM) in Patients With Colorectal Cancer

Cancer investigation, 2012-03, Vol.30 (3), p.225-230

2012

Volltextzugriff (PDF)

Artificial sweeteners—do they bear a carcinogenic risk?

Annals of oncology, 2004-10, Vol.15 (10), p.1460-1465

2004

Volltextzugriff (PDF)

Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma

Expert review of vaccines, 2011-03, Vol.10 (3), p.295-298

2011

Volltextzugriff (PDF)

In vivo peripheral expansion of naive CD4+CD25highFoxP3+ regulatory T cells in patients with multiple myeloma

Blood, 2006-05, Vol.107 (10), p.3940-3949

2006

Volltextzugriff (PDF)

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy

Leukemia & lymphoma, 2002-11, Vol.43 (11), p.2139

2002

Volltextzugriff (PDF)

Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment

Onkologie, 2008-09, Vol.31 (8-9), p.464-467

2008

Volltextzugriff (PDF)

Retrobulbar, Intracranial, and Cutaneous Secondary Plasmacytomas in a Patient with Atypical Multiple Myeloma

The New England journal of medicine, 2001-12, Vol.345 (26), p.1917-1917

2001

Volltextzugriff (PDF)

Comparative Approach to Define Increased Regulatory T Cells in Different Cancer Subtypes by Combined Assessment of CD127 and FOXP3

Clinical & developmental immunology, 2011-01, Vol.2011, p.734036-12

2011

Volltextzugriff (PDF)

Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies

Clinical & experimental metastasis, 2002-01, Vol.19 (7), p.617-621

2002

Volltextzugriff (PDF)

First Report and Results From VSCO.NET, the Virtual Society of Clinical Oncology, An Independent Internet-Based Haematology/Oncology Platform

Blood, 2010-11, Vol.116 (21), p.3832-3832

2010

Volltextzugriff (PDF)

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

Annals of hematology, 2002, Vol.81 (1), p.20-25

2002

Volltextzugriff (PDF)

Künstliche Süßstoffe – Haben sie ein kanzerogenes Potential?

Medizinische Klinik (München. 1983), 2001-11, Vol.96 (11), p.670-675

2001

Volltextzugriff (PDF)

Retrobulbar, Intracranial, and Cutaneous Secondary Plasmacytomas in a Patient with Atypical Multiple Myeloma: Letter

The New England journal of medicine, 2001-12, Vol.345 (26), p.1917

2001

Volltextzugriff (PDF)

1 - Grundlagen der Symptomtherapie

Internistische Therapie 2022 • 2023, 2022, p.3-46

24th Edition, 2022

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(60)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(31)
Male
(28)
Humans
(27)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Female
(17)
Animals
(16)
Middle Aged
(14)
Adult
(11)
Aged
(10)
Anesthesia
(10)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(10)
Oncology
(10)
Anesthesiology
(9)
Isoflurane - Pharmacology
(8)
Anesthetics, Inhalation - Pharmacology
(7)
Rabbits
(7)
Lymphoma
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Normalization of HE-stained histological images using cycle consistent generative adversarial networks

Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease : Potential for a prognostic factor

In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration

Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours

Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy

T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals

Toll-like receptor 9 agonists as cancer therapeutics

Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters

In vivo Expansion of Naïve CD4+CD25high FOXP3+ Regulatory T Cells in Patients with Colorectal Carcinoma after IL-2 Administration

Analysis of Tie2-Expressing Monocytes (TEM) in Patients With Colorectal Cancer

Artificial sweeteners—do they bear a carcinogenic risk?

Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma

In vivo peripheral expansion of naive CD4+CD25highFoxP3+ regulatory T cells in patients with multiple myeloma

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy

Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment

Retrobulbar, Intracranial, and Cutaneous Secondary Plasmacytomas in a Patient with Atypical Multiple Myeloma

Comparative Approach to Define Increased Regulatory T Cells in Different Cancer Subtypes by Combined Assessment of CD127 and FOXP3

Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies

First Report and Results From VSCO.NET, the Virtual Society of Clinical Oncology, An Independent Internet-Based Haematology/Oncology Platform

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

Künstliche Süßstoffe – Haben sie ein kanzerogenes Potential?

Retrobulbar, Intracranial, and Cutaneous Secondary Plasmacytomas in a Patient with Atypical Multiple Myeloma: Letter

1 - Grundlagen der Symptomtherapie

Suchergebnisse filtern